Salute e Benessere
Veterinary Infectious Disease Diagnostics Market worth US$4.22 billion by 2030 with 8.0% CAGR | MarketsandMarkets™
The rising trend of pet ownership also contributes to market growth, as pet owners are increasingly investing in advanced veterinary care, including early disease detection. Supportive government initiatives and increased research and development spending by key industry players also play a vital role in driving the expansion of this market.
In the veterinary infectious disease diagnostics market, the consumables segment held the largest market share in 2024. This dominance is primarily driven by the high and recurring demand for diagnostic test kits, reagents, and other consumable supplies used in routine testing for infectious diseases. Consumables are essential in reference laboratories, veterinary clinics, and point-of-care settings for conducting tests such as PCR, ELISA, lateral flow assays, and other molecular and immunodiagnostic procedures.
Unlike instruments, which are usually a one-time capital investment, consumables are utilized on a per-test basis, leading to continuous and increasing demand as testing volumes rise. The growing incidence of infectious diseases among animals, along with heightened awareness of the importance of early diagnosis and prevention, is significantly boosting the use of diagnostic consumables.
the molecular diagnostics segment is expected to be the fastest-growing area within the veterinary infectious disease diagnostics market due to its superior accuracy, sensitivity, and capability to detect pathogens at an early stage. Techniques such as polymerase chain reaction (PCR), real-time PCR (qPCR), and nucleic acid sequencing have become increasingly important for identifying infectious agents with high precision, even at low concentrations. A key factor driving this growth is the rising prevalence of complex and emerging infectious diseases in both companion and livestock animals, which require advanced and reliable detection methods. Molecular diagnostics provides faster turnaround times and greater specificity than conventional methods, allowing veterinarians to make quicker and more informed treatment decisions.
, in 2024, North America led the veterinary infectious disease diagnostics market, supported by a developed healthcare system and major diagnostic companies. The region boasts advanced diagnostic infrastructure, including reference laboratories and specialized veterinary hospitals. High investment in pet healthcare emphasizes preventive diagnostics and early disease detection. Increased awareness, better insurance coverage, and higher disposable income encourage timely veterinary care among pet owners in the US and Canada . Government initiatives aimed at controlling zoonotic diseases further boost the demand for diagnostics, while a robust regulatory framework ensures quality products and quicker tech approvals.
The prominent players in the veterinary infectious disease diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Virbac ( France ), bioMérieux ( France ), Antech Diagnostics, Inc. (US), Innovative Diagnostics ( France ), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH ( Germany ), and Agrolabo S.p.A. ( Italy ).
IDEXX Laboratories Inc. is a global medical technology company focused on products and services for companion animals, livestock, poultry, dairy, and water testing. It operates through four segments: Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy (LPD), and Others. The CAG segment includes diagnostic solutions and veterinary software, while the LPD segment offers diagnostic products for various farm animals. The company has sales offices in leading regions and markets its products in over 175 countries. In 2023, the CAG segment reported a revenue growth of 6.4%, driven by increased testing volumes and higher unit sales prices. In 2024, 5.6% of the total revenue was allocated to research and development.
Zoetis Services LLC focuses on discovering, developing, and commercializing animal health products, including vaccines, medicines, diagnostics, and genetic tests for companion animals (like dogs and cats) and livestock (such as cattle and poultry). Operating in the US and internationally, it offers a range of product categories, including anti-infectives, vaccines, and diagnostics. Its immunodiagnostic products use tests like ELISA and rapid immune migration. With operations in 45 countries and products sold in over 100, the company has over 300 R&D programs and spent USD 686 million on expenses. In January 2024 , it expanded its Vetscan Imagyst platform to include AI Urine Sediment analysis for diagnosing infections like UTIs.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/veterinary-infectious-disease-diagnostics-market-worth-us4-22-billion-by-2030-with-8-0-cagr--marketsandmarkets-302528758.html